Atlas
Back to Accounting Roll-Ups
Target·Accounting Roll-Ups

Xaira Therapeutics

San Francisco Bay Area, Californiawww.xaira.com1expert edge

AI-driven drug discovery company founded 2024 and launched with $1 billion+ in capital from ARCH Venture Partners, Sequoia Capital, and others; integrating machine learning with therapeutic development.

Why interesting to a deal team

Xaira's $1 billion launch round with Sequoia co-lead demonstrates pattern of backing transformational AI-enabled platforms reshaping industries; represents biotech's shift toward AI-powered discovery as key value lever.

Experts connected to this company

RB

Roelof Botha

Managing Partner

Sequoia Capital

Fund GPSan Francisco Bay Area

Two-decade Sequoia dealmaker and former Sequoia steward with deep board experience (MongoDB, Block) and a network spanning growth-stage software and fintech.

Sources